Milene Tatari Saavedra
Physician in Denver, CO
License number
Colorado 39114
Issued Date
Oct 19, 2000
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
1400 Jackson Street-A530, Denver, CO 80206
Professional information
Dr. Milene T Saavedra, Denver CO - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
1400 Jackson St, Denver 80206
(303) 398-1178 (Phone)
(303) 398-1178 (Phone)
Certifications:
Critical Care Medicine, 2002, Internal Medicine, 2010, Pulmonary Disease, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1400 Jackson St, Denver 80206
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
National Jewish Health
1400 Jackson St, Denver 80206
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16 Ave, Aurora 80045
National Jewish Health
1400 Jackson St, Denver 80206
Education:
Medical School
University Of Florida College Of Medicine
Graduated: 1996
University Of Florida College Of Medicine
Graduated: 1996
Milene Saavedra, Denver CO
Work:
Main Campus
1400 Jackson St, Denver, CO 80206
1400 Jackson St, Denver, CO 80206
Markers For Diagnosis Of Pulmonary Inflammation And Methods Related Thereto
US Patent:
2009023, Sep 17, 2009
Filed:
Mar 10, 2009
Appl. No.:
12/401381
Inventors:
Milene Saavedra - Denver CO, US
Jerry Nick - Denver CO, US
Jerry Nick - Denver CO, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention is related to the novel discovery of a number of genes that were identified as systemic markers of pulmonary inflammation. This discovery allows for development of a novel tool for reliable, rapid and efficient assessment of therapeutic responses and enables design of novel therapies targeted against diseases associated with pulmonary inflammation. In one embodiment, the present invention allows quantification of therapeutic response in patients who have a disease associated with pulmonary inflammation. In preferred embodiments, the genes are CD64, ADAM9, CD36, IL32, HPSE, PLXND1, HCA112, CSPG2, TLR2, and CD163.
Markers For Diagnosis Of Pulmonary Inflammation And Methods Related Thereto
US Patent:
8465923, Jun 18, 2013
Filed:
Dec 16, 2011
Appl. No.:
13/328886
Inventors:
Milene Saavedra - Denver CO, US
Jerry Nick - Denver CO, US
Jerry Nick - Denver CO, US
Assignee:
National Jewish Health - Denver CO
International Classification:
C12Q 1/68, C07H 21/02, C07H 21/04
US Classification:
435 611, 435 61, 435 613, 435 617, 435 618, 536 235, 536 2431
Abstract:
The present invention is related to the novel discovery of a number of genes that were identified as systemic markers of pulmonary inflammation. This discovery allows for development of a novel tool for reliable, rapid and efficient assessment of therapeutic responses and enables design of novel therapies targeted against diseases associated with pulmonary inflammation. In one embodiment, the present invention allows quantification of therapeutic response in patients who have a disease associated with pulmonary inflammation. In preferred embodiments, the genes are CD64, ADAM9, CD36, IL32, HPSE, PLXND1, HCA 112, CSPG2, TLR2, and CD163.